TWAV Q3 2022 Earnings Deep Earnings Miss Amid Ongoing Development Phase Grace Therapeutics Inc GRCE Q1 2026 Earnings Narrowed Loss Beats Expectations Despite Stock Dip SCCO Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience LWAY Q1 2026 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower APPN Q1 2026 Earnings EPS Surge Beats Estimates by 44 KEQU Q1 2026 Earnings Profitability Maintained Despite Missing Revenue Disclosure